Variations in the protective immune response against streptococcal superantigens in populations of different ethnicity

Medical Microbiology and Immunology

Volumn 195, Issue 1, 2006, Pages 37-43

  Yang, Lily P H ^a   Eriksson, Björn K G ^b,e   Harrington, Zinta ^c,f   Curtis, Nigel ^d   Lang, Selwyn ^b   Currie, Bart J ^c   Fraser, John D ^a   Proft, Thomas ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b MIDDLEMORE HOSPITAL   (New Zealand)

^c MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f FLINDERS UNIVERSITY   (Australia)

Author keywords

Acute rheumatic fever; Group A streptococcus (GAS); Invasive streptococcal disease; Neutralizing antibodies; Streptococcal superantigen

Indexed keywords

NEUTRALIZING ANTIBODY; RECOMBINANT ANTIGEN; STREPTOCOCCUS ANTIGEN; SUPERANTIGEN;

ABORIGINE; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUSTRALIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ETHNIC DIFFERENCE; EUROPE; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION SENSITIVITY; MALE; MAORI; MITOGENICITY; NEW ZEALAND; PACIFIC ISLANDER; PREDICTION; PRIORITY JOURNAL; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SEROCONVERSION; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BIOLOGICAL MARKERS; CELL PROLIFERATION; DISEASE SUSCEPTIBILITY; ETHNIC GROUPS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; SEROEPIDEMIOLOGIC STUDIES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 30544431598     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-005-0245-6     Document Type: Article

References (20)

1. Ayoub EM, Nelson B, Shulman ST, Barren DJ, Campbell JD, Armstrong G et al (2003) Group A streptococcal antibodies in subjects with or without rheumatic fever in areas with high or low incidences of rheumatic fever. Clin Diagn Lab Immunol 10(5):886-890
2. Basma H, Norrby-Teglund A, Guedez Y, McGreer A, Low DE, El-Ahmedy O et al (1999) Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. Infect Immun 67(4):1871-1877
3. Bhatnagar A, Grover A, Ganguly NK (1999) Superantigen-induced T cell responses in acute rheumatic fever and chronic rheumatic heart disease patients. Clin Exp Immunol 116(1):100-106
4. Bonventre PF, Heeg H, Cullen C, Lian CJ (1993) Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome. Infect Immun 61(3):793-799
5. Carapetis JR, Wolff DR, Currie BJ (1996) Acute rheumatic fever and rheumatic heart disease in the Top End of Australia's Northern Territory. Med J Aust 164:146-149
6. Eriksson BKG, Andersson J, Holm SE, Norgen M (1999) Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. J Infect Dis 180:410-418
7. Finger F, Rossaak M, Umstaetter R, Reulbach U, Pitto R (2004) Skin infections of the limbs of Polynesian children. N Z Med J 117(1192):847-851
8. Herman A, Kappler JW, Marrack P, Pullen AM (1991) Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol 9:742-772
9. Kaplan EL (1991) The resurgence of group A streptococcal infections and their sequelae. Eur J Clin Microbiol Infect Dis 10(2):55-57
10. Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, O'Rourke K et al (1999) Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome - a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis 28(4):800-807
11. Miethke T, Wahl C, Heeg K, Echtenacher B, Krammer PH, Wagner H (1992) T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med 175:91-98
12. Proft T, Schrage B, Fraser JD (2005) Superantigens - microbial toxins that target the immune system. In: Proft T (ed) Microbial toxins: molecular and cellular biology, horizon bioscience. Wymondham, UK, pp 179-213
13. Proft T, Sriskandan S, Yang, L, Fraser JD (2003) Superantigens and streptococcal toxic shock syndrome. Emerg Infect Dis 9(10):1211-1218
14. Proft T, Webb PD, Handley V, Fraser JD (2003) Two novel superantigens found in both group A and group C streptococcus. Infect Immun 71(3):1361-1369
15. Smoot LM, McCormick JK, Smoot JC, Hoe NP, Strickland I, Cole RL et al (2002) Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks. Infect Immun 70:7095-7104
16. Sriskandan S, Moyes D, Cohen J (1996) Detection of circulating bacterial superantigen and lymphotoxin-α in patients with streptococcal toxic-shock syndrome. Lancet 348:1315-1316
17. Stevens DL (2000) Streptococcal toxic shock syndrome associated with necrotizing fasciitis. Annu Rev Med 51:271-288
18. Taylor FB Jr, Bryant AE, Blick KE, Hack E, Jansen PM, Kosanke SD et al (1999) Staging of the baboon response to group A streptococci administered intramuscularly: a descriptive study of the clinical symptoms and clinical chemical response patterns. Clin Infect Dis 29(1):167-177
19. Unnikrishnan M, Altmann DM, Proft T, Wahid F, Cohen J, Fraser JD, Sriskandan S (2002) The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenes. J Immunol 169:2561-2569
20. Urdahl KB, Mathews JD, Currie BJ (1996) Anti-streptokinase antibodies and streptokinase resistance in an Aboriginal population in northern Australia. Aust NZ J Med 26:49-53